Sema4 Holdings Corp. announced that James Coffin, Ph.D., the President, and Chief Operating Officer, will leave the company for personal reasons, effective February 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.3 USD | +3.87% |
|
+6.42% | +1,110.91% |
Jul. 10 | Craig-Hallum Initiates Coverage on GeneDx With Buy Rating, $43 Price Target | MT |
Jul. 01 | GeneDx Holdings Corp.(NasdaqGS:WGS) added to Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1,110.91% | 838M | |
-16.93% | 8.48B | |
+79.26% | 4.81B | |
+16.31% | 2.99B | |
-3.15% | 2.65B | |
-4.20% | 2.02B | |
-52.37% | 1.87B | |
-13.53% | 1.58B | |
+21.59% | 1.25B | |
-47.00% | 1.06B |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- James Coffin to Leave Sema4 Holdings Corp. as President, and Chief Operating Officer